drugset / Trial / NCT02072278

Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects

NCT02072278

Phase 1 Completed 32 enrolled H. Lundbeck A/S
RandomizedCrossoverDouble-blindTreatment

Summary

To explore a neurophysiological marker (electroencephalography) of cognitive effect of vortioxetine

Timeline

Start
2014-02
Primary completion
2014-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 15 mg Oral
Subject Vortioxetine Unknown 10 mg Oral
Subject Vortioxetine Unknown 20 mg Oral

Indications

No indication recorded.